CLARTEIS

RQM+ is a global MedTech Contract Research Organization (CRO) headquartered in Cary, North Carolina, specializing in regulatory affairs, quality assurance, clinical trials, laboratory services, and reimbursement strategies for medical devices, in-vitro diagnostics, and software-enabled products. Founded in 2008 and rebranded following the 2020 acquisition of Maetrics, RQM+ provides comprehensive support throughout the product life cycle with a focus on regulatory compliance and market access. The company operates FDA-recognized laboratory services through Jordi Labs (offering materials testing and chemical characterization) and delivers flexible partnering models including full-service outsourcing, consulting, and staff augmentation. RQM+ serves 19 of the top 20 medical device companies and 7 of the top 10 IVD companies, with global presence across the U.S., Europe, and the U.K., leveraging proprietary technology platforms to accelerate time to market and reduce regulatory risk.